Search results for: 'initial impact'

Rising incidents of patient deaths are raising questions about medical device efficacy, specifically Class II and Class III medical devices. All medical devices commercialized in the US market must adhere to 510(k) compliance. The US Food and Drug Administration (FDA) posts summaries of information about the most serious medical device recalls. ...

Retail health providers fill the traditional healthcare void by offering healthcare services, such as pharmacy, preventive care, urgent care, chronic condition management, vaccinations, telehealth, wellness, and an emerging focus on women’s health. High cost is a barrier to healthcare and medication access, affecting uninsured and aged populations ...

The study offers an overview of the impact of COVID-19 on select medical devices. The deferral of elective procedures due to COVID-19-related measures has affected the cardiovascular medical device market. While some cardiovascular procedures are considered urgent, others have been rescheduled and deferred. Nearly 83.5% of all orthopedic procedures...

Precision medicine is transitioning toward wider acceptance, due to mounting payer pressures and regulatory changes that are shifting pharma businesses from prescriptive to more predictive and personalized models. Emergence of value-based reimbursement models and healthcare consumerism trends are helping move the treatment model from ‘one-size-fits...

31 Mar 2020  |  North America  |  Technology Research

Medical Devices in 2025: An AI Impact Analysis

Transforming Medical Imaging, Patient Monitoring, Ophthalmic and Cancer Diagnostics through Implementation of AI

Infographics

×

Medical device manufacturers are increasingly incorporating artificial intelligence (AI) in their systems with the aim to better assist healthcare providers and also improve care provided to the patients. AI systems have the ability to acquire data, deploy logical rules for processing the data, generate reasonable solutions and automatically recogn...

Cardiometabolic diseases, including cardiovascular disease (which encompasses coronary artery diseases, chronic/congestive heart failure, stroke, and hypertension), type 2 diabetes, and obesity, have been increasing globally. As a result, the healthcare cost burden has become significant and is anticipated to rise further. Existing drug therapies f...

Clinical genomics regained significance during the pandemic with the development of the mRNA COVID-19 vaccine, and several non-invasive at-home test kits; an unprecedented feat in recent times. Genomics will take center stage, as large genome sequencing and research will continuously create data for new therapeutics. Artificial Intelligence (AI) an...

The global decentralized clinical trial (DCT) market has been witnessing a continued surge after the COVID-19 pandemic. The accelerated DCT adoption in 2020 was driven by restricted mobility of site investigators, clinical research associates, and patients to participate in trials, which resulted in a significant halt in trial activities worldwide....

30 Jun 2023  |  North America  |  Market Research

Global Telehealth Growth Opportunities

Value-based Care Goals and Health Equity Initiatives Spur Future Growth Potential

Infographics

×

Telehealth is gaining popularity as it saves healthcare costs and hospital travel time. It is convenient for consumers, especially the elderly and disabled, to access services from home. Healthcare organizations have been facing skilled workforce shortages and clinician burnout across the world, leading to burdened healthcare systems. Telehealt...